Your key research partner
Since 1960, Janvier Group has been a global leader in biosciences, providing integrated solutions across the complete drug development continuum.
Years of
excellence
Clients globally
Of the Top 20 pharma
Quality as our
#1 priority
Why work with a group ?
Expertise
Best-in class specialists working together
Speed
Seamless project handover
Efficiency
Simplified admin & logistics
Our teams operate as an integrated network, eliminating silos and accelerating project workflows to keep the focus where it belongs: innovating and achieving your research goals.
Our experts
What our clients say
Consistently high standards, reliable timelines and constructive scientific discussions.
Very high-quality data on the models offered, smooth collaboration with excellent support.
A highly reliable partner with deep scientific expertise and a very responsive team.
Can’t thank you enough for all your great work and support! It was really nice collaborating with you all and I am very much looking forward to our next collaboration!
Excellent scientific advice provided for the study design. Studies tailored for small biotechs with limited budget. Timelines met, rigor in execution. Indeed, a great partner for drug development in the metabolic disease area.
Great working with your company: great competence in the area, straight answers and very good team available to support all our needs.
Consistently high standards, reliable timelines and constructive scientific discussions.
Very high-quality data on the models offered, smooth collaboration with excellent support.
A highly reliable partner with deep scientific expertise and a very responsive team.
Can’t thank you enough for all your great work and support! It was really nice collaborating with you all and I am very much looking forward to our next collaboration!
Excellent scientific advice provided for the study design. Studies tailored for small biotechs with limited budget. Timelines met, rigor in execution. Indeed, a great partner for drug development in the metabolic disease area.
Great working with your company: great competence in the area, straight answers and very good team available to support all our needs.
Our core strengths
Innovation
Our state-of-the-art models and associated services have been recognized for their ground-breaking impact in the scientific community.
Commitment to excellence
Our rigorous ISO-certified quality strategies help us consistently deliver outcomes that exceed expectations.
Global rich with local expertise
Our global presence and local teams ensure seamless collaboration across borders, making us the ideal partner for your international research needs.
Tailored solutions
We offer highly customized solutions that fit the specific needs of your research projects, based on a range of highly-specific, gold-standard models.
Maximizing R&D funding opportunities
Our official accreditations such as CIR allow clients to benefit from significant R&D tax incentives, streamlining their path to innovation.
Curiosity, creativity, passion
Our team's passion and enthusiasm drive every project we undertake. Our experts infuse creativity and dedication to every stage of your research.
Strong scientific support
We offer guidance with all our services. Join a team with experts available from start to finish to ensure the success of your projects.
Responsibility
We uphold the highest standards of sustainability, with strong commitment to Environmental, Social and Governance (ESG) principles.
Contact us
Frequently asked questions
Still have questions ?
Our experts are here to help – let’s collaborate on your next breakthrough.
What is Janvier Group Biosciences and what does the Group do?
Janvier Group Biosciences is a European life sciences group specialized in research models & services for academic, pharmaceutical, biotechnology organizations and CROs, to cite a few.
The Group brings together multiple expert companies providing drug discovery support, preclinical models and services, in vivo and in vitro studies, bioanalysis and biomanufacturing, helping clients advance innovative therapies toward the market.
Janvier group Biosciences is established in Europe and North America, with commercial offices and laboratories on both continents.
What types of preclinical and translational research services does Janvier Group Biosciences provide?
Janvier Group Biosciences offers a broad and integrated portfolio of preclinical services, including:
- antibody and small-molecule development support,
- preclinical models and services, including efficacy studies,
- oncology, metabolic, cardiovascular and urogenital research, among other therapeutic areas,
- clinical bioanalysis and biomarker-related activities,
- biomanufacturing of plasmids, proteins, cells and biologics.
How does Janvier Group Biosciences support drug discovery and development programs?
Janvier Group Biosciences supports drug discovery and development by acting as a scientific partner, not just a service provider.
Through its specialized entities, the Group helps clients:
- design relevant preclinical strategies,
- generate high-quality, decision-enabling data,
- combine complementary expertise across models, technologies and therapeutic areas,
- accelerate the transition from discovery to clinical development.
This integrated approach reduces fragmentation and increases program efficiency.
What makes Janvier Group Biosciences different from larger global providers?
Janvier Group Biosciences is built around highly specialized expert companies with deep scientific expertise.
The Group combines:
- tailored project execution,
- cross-entity synergies,
- scientist-to-scientist collaboration,
while maintaining flexibility, proximity to clients and a long-term partnership mindset.
Who are the typical clients of Janvier Group Biosciences?
Janvier Group Biosciences works with more than 3,500 clients, including:
- emerging and mid-size biotech companies,
- large international pharmaceutical companies,
- academic institutions,
- innovation-driven research organizations.
Clients are based in Europe, North America and other international markets, and typically engage the Group to address complex and innovative research challenges.
Still have questions ?
Our experts are here to help – let’s collaborate on your next breakthrough.